Fiche centre
Research Site
Qingdao — China
Essais liés3clinical trials
VilleQingdaolocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05556096
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MG Cohort — A Study in Patients With Myasthenia Gravis in China | Myasthénie | À vérifier | NCT06700616 | MG Cohort — A Study in Patients With Myasthenia Gravis in China | ACTIVE_NOT_RECRUITING |
| ALXN1720 | Myasthénie | Phase 3 | NCT05556096 | Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| Anifrolumab | Lupus | Phase 3 | NCT07751848 | LOTUS — A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus | NOT_YET_RECRUITING |